Yixintang Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Yixintang Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Yixintang") was established on November 8, 2000. Since its establishment for more than 20 years, Yixintang has deeply cultivated Yunnan and expanded nationwide. As of March 31, 2023, Yixintang and its wholly-owned subsidiaries have a total of 9344 direct chain stores, covering 10 provinces and municipalities including Yunnan, Guizhou, Guangxi, Qiong, Sichuan, Chongqing, Jin, Yu, Tianjin, and Shanghai. It is a well-known and leading listed drug retail chain enterprise in China. Yixintang has now developed into a large health platform enterprise that integrates pharmacy retail, biopharmaceutical, and medical care services. Its main businesses include chain retail, commercial wholesale, traditional Chinese medicine research and development production, biological herbal medicine planting, processing, and medical care industry. Yixintang has always adhered to the service principle of "serving the people with one heart, wholeheartedly", and adheres to serving every consumer with "love, care, sincerity, meticulousness, and perseverance", There are over 30 million effective members scattered throughout the country, serving 150 million customers annually. |
| Headquarter | Kunming |
| Establish Date | 11/8/2000 |
| Listed Code | 002727.SZ |
| Listed Date | 7/2/2014 |
| Chairman | Ruan Hongxian. |
| CEO | Ruan Hongxian. |
| Website | www.hx8886.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
